Agios Pharmaceuticals: 2Q Earnings Snapshot
Posted Jul 30, 2020 08:51:54 AM.
Last Updated Jul 30, 2020 09:02:50 AM.
This article is more than 5 years old.
CAMBRIDGE, Mass. (AP) _ Agios Pharmaceuticals Inc. (AGIO) on Thursday reported a loss of $90.5 million in its second quarter.
The Cambridge, Massachusetts-based company said it had a loss of $1.31 per share.
The results beat Wall Street expectations. The average estimate of five analysts surveyed by Zacks Investment Research was for a loss of $1.42 per share.
The biopharmaceutical company posted revenue of $37.3 million in the period, also surpassing Street forecasts. Four analysts surveyed by Zacks expected $35.4 million.
Agios Pharmaceuticals shares have risen 3.5% since the beginning of the year. The stock has risen roughly 9% in the last 12 months.
_____
This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on AGIO at https://www.zacks.com/ap/AGIO
The Associated Press
